Watch Our Weekly Webinar: MedTech Crossroads
Cytometry/Cell Counting

FROM: Early prototypes

TO: Market, patents

Part of the in2being staff heritage goes back to the very successful spin-out, Accuri Cytometers, acquired by Beckton-Dickinson in 2011. With staff participation that was core to Accuri’s success, in2being has been involved in developing cell counting and cytometry related prototypes. Our work spans the technological gamut, from fluidics and flow cells for sample processing to optics and electronics for scatter collection.



Let us get you there.

We're ready to lead you from concept, to prototype, to FDA clearance. Let us show you how to push your project forward with a free project analysis. Are you ready to bring your medical device to market?

Contact us to request your free analysis today.